Showing 601-610 of 2110 results for "".
Stroke Spotlight: Subarachnoid Hemorrhage and Cerebral Vasospasm
https://practicalneurology.com/diseases-diagnoses/stroke/stroke-spotlight-subarachnoid-hemorrhage-and-cerebral-vasospasm/31524/Cerebral vasospasm increases morbidity and mortality in persons with subarachnoid hemorrhage.Epilepsy Essentials: VideoEEG Analysis
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/epilepsy-essentials-videoeeg-analysis/31905/In this 2-part special report, complexities of performing and interpreting videoEEG are demystified.Epilepsy & Memory
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/epilepsy-memory/31592/Memory complaints in people with epilepsy remain challenging to assess and difficult to treat.Behavioral Approaches in Dementia Care
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/behavioral-approaches-in-dementia-care/31800/The many behavioral and psychologic symptoms of dementia have a large effect on patient and caregiver outcomes.Blood-Based Biomarkers in Alzheimer Disease: Clinical Implementation and Limitations
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/blood-based-biomarkers-in-alzheimer-disease-clinical-implementation-and-limitations/32100/Although biomarkers for Alzheimer disease have the potential to improve evaluation and care, barriers to implementation remain.- In Memoriam: Ralph L. Sacco, MD, MS, FAHA, FAANhttps://practicalneurology.com/news/in-memoriam-ralph-l-sacco-md-ms-faha-faan/2470102/
- FDA Clears L-4-Chlorokynurenine for Phase 2 Trials in Levodopa-Induced Dyskinesiahttps://practicalneurology.com/news/fda-clears-l-4-chlorokynurenine-for-phase-2-trials-in-levodopa-induced-dyskinesia/2469143/The Food and Drug Administration (FDA) has cleared an investigational new drug (IND) application for L-4-chlorokynurenine (AV-101, VistaGen Therapeutics, South San Francisco, CA), as a potential treatment for levodopa-induced dyskinesia. The FDA's IND clearance permits the procession of the p
- Remembering Ronald DeVere, MD, FAANhttps://practicalneurology.com/news/remembering-ronald-devere-md-faan/2470936/Ronald DeVere, MD, FAAN, Practical Neurology Editorial Advisory Board member and former Editor of the Dementia Insights column, passed away on May 8, 2024, at age 80. Dr. DeVere served as the Director of the Taste & Smell Disorders Clinic and the Alzheimer Disease & Memory Disorder
- Catherine Chu, MD, to Lead Pediatric Neurology at Kennedy Krieger and Johns Hopkinshttps://practicalneurology.com/news/catherine-chu-md-to-lead-pediatric-neurology-at-kennedy-krieger-and-johns-hopkins/2475483/Catherine Chu, MD, MA, MMSc, has been named Vice President of Child Neurology of the Kennedy Krieger Institute and will also serve as Director of the Division of Pediatric Neurology and the John M. Freeman Pediatric Epilepsy Center at Johns Hopkins Children’s Center. According to a statement rele
- In Memoriam: Martin A. Samuels, MD, DSc (hon), FAAN, MACP, FRCP, FANAhttps://practicalneurology.com/news/in-memoriam-martin-a-samuels-md-dsc-hon-faan-macp-frcp-fana/2470226/Martin A. Samuels, MD, DSc (hon), FAAN, MACP, FRCP, FANA, the first named Miriam Sydney Joseph Distinguished Professor of Neurology at Harvard Medical School, passed away on June 6, 2023, at age 77.